InsidersTradesSigma
Track the REVOLUTION MEDICINES INC stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €44.6bn. The latest transaction was filed on 21 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: MARGARET A HORN. All data is openly available.
Analysts rate REVOLUTION MEDICINES INC Strong Buy (bullish), based on 21 analysts. Average price target: US$247.11.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
REVOLUTION MEDICINES INC is a biopharmaceutical company focused on developing targeted treatments for cancer. It employs an innovative approach to identify and develop drugs that block tumor-specific signaling pathways.